Medicinal Cannabis Matters | Friday roundup 3rd January 2025.
Medicinal Cannabis Matters | Friday roundup 3rd Jan 2025
Medicinal Cannabis Matters – Our weekly round-up of what has been happening in the world of medicinal cannabis this week.
This week, we look into a study examining the effects of medicinal cannabis on patients with inflammatory bowel disease, explore how arthritis patients are experiencing significant relief through medicinal cannabis treatments, and highlight the growing availability of educational programs focused on medicinal cannabis.
Medicinal Cannabis provides improvements in patients with Inflammatory Bowel Disease.
A study conducted in London, UK, reveals that patients diagnosed with inflammatory bowel disease have reported sustained improvements in their health-related quality of life following their use of medicinal cannabis.
Arthritis patients report substantial improvements from medicinal cannabis use.
Arthritis patients have experienced pain relief following medicinal cannabis treatments. Many have also reported improvements in stiffness, fatigue, and joint swelling—common symptoms associated with the condition.
Medicinal cannabis in the classroom: educational programs paving the way for industry growth.
As society’s perception of cannabis evolves, the importance of education and the demand for skilled professionals in the field are growing rapidly. Various institutions have begun to offer dedicated programs related to cannabis, ranging from short courses to full degree programs.
If you’re interested in learning more about medicinal cannabis and how it can help you manage your condition, fill out the simple form linked below. Start your journey today with the only award-winning clinic in Jersey, Guernsey and the Isle of Man. Check your eligibility today.
https://www.medicann.co.uk/book-consultation/eligibility/
Disclaimer:
This blog post and the following featured articles are for information only and any articles on external platforms may be amended at any time. Articles that we refer to in our weekly roundup do not reflect the views of Medicann.
